A First-in-Human Phase 1b, Single-Blind, Placebo-controlled Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Evaluate Safety and Pharmacokinetics of GS-0415 in People With HIV-1 who are Virologically Suppressed on Antiretroviral Treatment

17066GS-US-531-7345OpenA First-in-Human Phase 1b, Single-Blind, Placebo-controlled Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Evaluate Safety and Pharmacokinetics of GS-0415 in People With HIV-1 who are Virologically Suppressed on Antiretroviral TreatmentNCT07719491IndustrialAdultTreatmentI/IINationalOtherKumar, PrincyGeorgetown University Medical Center : Jai Kumar; Lombardi Comprehensive Cancer Center : Jai KumarGUMC Medicine Infectious Disease8541Jai KumarJai KumarJK683@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>